This inventor holds 1 USPTO granted patent. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations in Cancer Treatment by Serge Lyashchenko
Introduction
Serge Lyashchenko is a notable inventor based in New York, NY, who has made significant contributions to the field of cancer treatment. His work focuses on developing advanced therapeutic agents that target specific cancer types, particularly those that are PSMA positive.
Latest Patents
Lyashchenko holds a patent for "Theranostic agents for PSMA positive cancers." This patent encompasses compositions and methods for the detection and treatment of cancer. The technology includes novel radiohalogenated PSMA targeting agents, which are utilized in diagnostic imaging and radiation therapy. His innovative approach aims to enhance the effectiveness of cancer treatment while minimizing side effects.
Career Highlights
Serge Lyashchenko is affiliated with the Memorial Sloan Kettering Cancer Center, a leading institution in cancer research and treatment. His role at this prestigious center allows him to collaborate with other experts in the field and contribute to groundbreaking research that has the potential to change the landscape of cancer therapy.
Collaborations
One of his notable collaborators is Teja Muralidhar Kalidindi. Together, they work on advancing the understanding and treatment of cancer, leveraging their combined expertise to develop innovative solutions.
Conclusion
Serge Lyashchenko's contributions to cancer treatment through his patented innovations highlight the importance of targeted therapies in modern medicine. His work at Memorial Sloan Kettering Cancer Center exemplifies the potential of research and collaboration in the fight against cancer.